Immediate Impact
24 standout
Citing Papers
GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review
2024 Standout
Current advance of nanotechnology in diagnosis and treatment for malignant tumors
2024 Standout
Works of Timothy M. Schmidt being referenced
Gain of Chromosome 1q is associated with early progression in multiple myeloma patients treated with lenalidomide, bortezomib, and dexamethasone
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Timothy M. Schmidt | 446 | 375 | 253 | 29 | 546 | |
| G Tricot | 297 | 147 | 192 | 21 | 545 | |
| Raija Silvennoinen | 293 | 173 | 205 | 37 | 550 | |
| Geraldine Ferron‐Brady | 199 | 311 | 195 | 32 | 548 | |
| Jean‐Gabriel Fuzibet | 414 | 338 | 233 | 18 | 534 | |
| Laura Pattacini | 195 | 158 | 86 | 26 | 619 | |
| Cristina João | 197 | 143 | 177 | 41 | 565 | |
| Maarten E. Emmelot | 207 | 165 | 132 | 24 | 530 | |
| Patricia Walker | 242 | 185 | 138 | 54 | 603 | |
| HP Kiem | 103 | 312 | 121 | 23 | 492 | |
| CN Abboud | 209 | 113 | 129 | 26 | 590 |
All Works
Login with ORCID to disown or claim papers
Loading papers...